CommercialCoverageMedium impact
PAP271 - Infusion Therapy Guidelines for Non-Home Infusion, Specialty Infusion and Specialty Pharmacy Providers - Added reference to MP 5.01.502
Blue Cross of Idaho·ID · Oncology, Hematology, Gastroenterology +4 more·Pharmacy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Blue Cross of Idaho updated their infusion therapy policy PAP271 to add a reference to Medical Policy 5.01.502, which identifies medical drugs not eligible for reimbursement. This provides clearer guidance on which infusion drugs will not be covered.
Action Required
Immediately: Billing team must reference new Medical Policy MP 5.01.502 to identify medical drugs not eligible for reimbursement before submitting infusion therapy claims. Update prior authorization verification process to cross-check drugs against both MP 5.01.500 (preferred drugs) and MP 5.01.502 (non-covered drugs). Continue ensuring all infusion therapy claims include NDC codes and narrative drug descriptions to avoid denials.